The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.

Miguel Angel PavónIrene Arroyo-SoleraXavier Leon VintroMarta Téllez-GabrielDavid VirósAlberto GallardoMaria Virtudes CéspedesIsolda CasanovaAntonio Lopez-PousaAgustí BarnadasMiquel QuerMiguel Ángel Pavón

Published in: Head & neck (2019)

EFS, GPX2, and SPRR1A are prognostic markers able to distinguish clinical outcome among subtypes sharing an EL phenotype.

Keyphrases

poor prognosis
social media
health information
binding protein
healthcare